BJU Int 2021 Dec 13
The clinical characteristics of patients with primary non-prostate-specific membrane antigen-expressing prostate cancer on preoperative positron emission tomography/computed tomography.
Related Questions
Pretreatment PSA 25.3 with Gleason 4+3=7 and MRI suspicious for ECE. Eight months after pelvic nodal and prostate XRT to 79 Gy, PSA is 5.02 (down from...
New comment by Radiation Oncologist at Vanderbilt-Ingram Cancer Center ( July 21, 2023)
It's an excellent question, Dr. @Pollock. I do not think there is utility of repeating a PSMA PET in the post-treatment scenario as described.
While I personally wait for Pho...